Cargando…

Global Thrombosis Test – a possible monitoring system for the effects and safety of dabigatran

BACKGROUND: Dabigatran is an alternative to warfarin (WF) for the thromboprophylaxis of stroke in patients with non-valvular atrial fibrillation (NVAF). The advantage of dabigatran over WF is that monitoring is not required; however, a method to monitor the effect and the safety of dabigatran is not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Otsui, Kazunori, Gorog, Diana A., Yamamoto, Junichiro, Yoshioka, Takayuki, Iwata, Sachiyo, Suzuki, Atsushi, Ozawa, Toru, Takei, Asumi, Inoue, Nobutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Original Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672538/ https://www.ncbi.nlm.nih.gov/pubmed/26648789 http://dx.doi.org/10.1186/s12959-015-0069-6

Ejemplares similares

Vasospastic Angina in Identical Twins
por: Yoshioka, Takayuki, et al.
Publicado: (2015)

Coconut Atrium in Long-Standing Rheumatic Valvular Heart Disease
por: Onishi, Takahisa, et al.
Publicado: (2015)

A Case with Recurrent Free-Floating Ball Thrombi in Left Atrium
por: Yoshioka, Takayuki, et al.
Publicado: (2017)

Prevention of thrombotic disorders by antithrombotic diet and exercise: evidence by using global thrombosis tests
por: Yamamoto, Junichiro, et al.
Publicado: (2018)

A point-of-care global thrombosis test measuring occlusion time and endogenous lysis time may indicate thrombotic status
por: Yamamoto, Junichiro, et al.
Publicado: (2019)

A case of atrial standstill with the atrial lead of a dual-chamber pacemaker implanted in the coronary sinus
por: Suzuki, Yuya, et al.
Publicado: (2019)

Global Thrombosis Test: Occlusion Is Attributable to Shear-Induced Platelet Thrombus Formation
por: Gorog, Diana A., et al.
Publicado: (2021)

Global thrombosis test for assessing thrombotic status and efficacy of antithrombotic diet and other conditions
por: Murakami, Masahiro, et al.
Publicado: (2022)

A case of mitochondrial cardiomyopathy with restrictive transmitral filling pattern
por: Otsui, Kazunori, et al.
Publicado: (2012)

Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial
por: Ferro, José M., et al.
Publicado: (2019)

Possible renoprotective effects of dabigatran
por: Karahan, Oğuz
Publicado: (2015)

Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay
por: Imamura, Kimitake, et al.
Publicado: (2013)

Dabigatran in Cerebral Sinus Vein Thrombosis and Thrombophilia
por: Kellermair, Lukas, et al.
Publicado: (2022)

Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance
por: Inoue, Hiroshi, et al.
Publicado: (2016)

Interstitial pneumonia caused by dabigatran
por: Yanagihara, Toyoshi, et al.
Publicado: (2017)

Dabigatran for left atrial thrombus
por: Morita, Sae, et al.
Publicado: (2013)

Critical appraisal of dabigatran in the treatment of deep vein thrombosis and pulmonary embolism
por: Ogbonna, Kelechi C, et al.
Publicado: (2015)

Dabigatran as an alternative for atrial thrombosis resistant to rivaroxaban: A case report
por: Sun, Huan, et al.
Publicado: (2018)

Possible Interaction between Dabigatran and Ranolazine in Patients with Renal Failure
por: Gumbrevičius, Gintautas, et al.
Publicado: (2019)

Association of a Body Shape Index as a Novel Anthropometric Indicator with Subclinical Atherosclerosis
por: Otsui, Kazunori
Publicado: (2022)

Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement
por: Gorog, Diana A., et al.
Publicado: (2020)

Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
por: Kim, Jong-Min, et al.
Publicado: (2022)

Enhanced pre-operative thrombolytic status is associated with the incidence of deep venous thrombosis in patients undergoing total knee arthroplasty
por: Tamura, Yukinori, et al.
Publicado: (2014)

Incidence of thrombotic complications in COVID-19: On behalf of ICODE: The International COVID-19 Thrombosis Biomarkers Colloquium
por: Jenner, William J., et al.
Publicado: (2021)

The Dabigatran debate
por: Kaba, Riyaz A, et al.
Publicado: (2014)

Glucocorticoid in Combination with a TNF-α Inhibitor: Treatment of Deep Vein Thrombosis in a Patient with Behçet's Disease
por: Okano, Mitsumasa, et al.
Publicado: (2022)

A Case of Treatment With Dabigatran for Cerebral Venous Thrombosis Caused by Hereditary Protein C Deficiency
por: Fukushima, Taiki, et al.
Publicado: (2021)

Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis
por: Zhou, Haonan, et al.
Publicado: (2023)

Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting
por: Rosencher, Nadia, et al.
Publicado: (2016)

Splenic Vein Diameter is a Risk Factor for the Portal Venous System Thrombosis After Partial Splenic Artery Embolization
por: Ogawa, Satoyuki, et al.
Publicado: (2021)

The Discovery of Dabigatran Etexilate
por: van Ryn, Joanne, et al.
Publicado: (2013)

Dabigatran and apolipoprotein B
por: ten Cate, Hugo
Publicado: (2016)

Resolution of Primary Aortic Thrombosis after Dabigatran therapy—A New Hope for the Rare and Old Disease
por: Jariwala, Pankaj, et al.
Publicado: (2019)

A Case Report of Rivaroxaban-Induced Urticaria and Angioedema With Possible Cross-Reaction to Dabigatran
por: Patil, Tanvi, et al.
Publicado: (2019)

Dabigatran-induced Esophageal Ulcer at a Natural Constriction
por: Sasaki, Sho, et al.
Publicado: (2018)

Effectiveness of Saireito, a Traditional Japanese Kampo Herbal Medication, on Pacemaker-Related Pleural Effusion: A Case Report
por: Mataki, Hiroyuki, et al.
Publicado: (2021)

Acute Onset of Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Two Weeks After COVID-19 Vaccination With mRNA-1273 With Possible Activation of Parvovirus B19: A Case Report With Literature Review
por: Arino, Hiroto, et al.
Publicado: (2022)

Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis
por: Memtsas, Vassilios P., et al.
Publicado: (2021)

The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination
por: Glund, Stephan, et al.
Publicado: (2018)

More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy—Current Data and Future Directions
por: Spinthakis, Nikolaos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5neia41ahmubm2qraj229fe78s